Gu Chun-hua, Wu Yi-ling, Tian Shu-yan, Gao Xuedong, Qi Xiaolin, Jia Zhenhua, Yang Libo, Li Yunpeng, Xu Guicheng
Medicinal Academy, Shijiazhuang.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Sep;25(9):783-6.
To observe the clinical efficacy of shensong yangxin capsule (SYC) on ventricular premature beat (VPB) differentiated in TCM as palpitation of Qi-yin deficiency syndrome or Xin collateral stagnation syndrome, and cardiovascular autonomic nervous function in patients with coronary heart disease (CHD).
The randomized, double-blind, parallel contrast method was adopted, patients were randomly assigned by 3:1 ratio into two groups. One hundred and sixty-five patients in SYC treated group and 56 in the control group (treated with Xinlvning tablet), and the therapeutic course for both groups was 4 weeks.
The clinical efficacy on VPB and in improving TCM syndromes was better in SYC group than that in the control group (P < 0.01). After treatment, the heart rate variability (HRV) and QT dispersion in the two groups were improved in a certain degree. The changes of SDNN, SDANN, SDNN Index and PNN50 in the two groups were significantly different (P < 0.05, P < 0.01), the efficacy in the treated group was superior to that in the control group.
SYC has definite effect on VPB and TCM Syndromes, it can obviously meliorate the activity of cardiovascular autonomic nervous system in the patients with CHD.
观察参松养心胶囊(SYC)对冠心病(CHD)患者中医辨证为气阴两虚证或心络瘀阻证室性早搏(VPB)及心血管自主神经功能的临床疗效。
采用随机、双盲、平行对照法,患者按3:1比例随机分为两组。参松养心胶囊治疗组165例,对照组56例(服用心律宁片),两组疗程均为4周。
参松养心胶囊组对室性早搏及改善中医证候的临床疗效优于对照组(P<0.01)。治疗后,两组心率变异性(HRV)及QT离散度均有一定程度改善。两组SDNN、SDANN、SDNN Index及PNN50变化差异有统计学意义(P<0.05,P<0.01),治疗组疗效优于对照组。
参松养心胶囊对室性早搏及中医证候有确切疗效,能明显改善冠心病患者心血管自主神经系统活性。